Clinical Trial Update: A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney Disease [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase IIb, multicenter, open-label trial evaluating Bremelanotide in diabetic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease

Drugs mentioned

• Bremelanotide (bremelanotide)

Snippet

Sponsor: Palatin Technologies, Inc | Conditions: Kidney Disease | Phase 2 | Status: COMPLETED